The Kings New York Warrant Agreement, also known as the Kings NY Warrant, is a legal document that outlines the terms and conditions for purchasing shares of common stock in Immunomedics, Inc. It is an agreement between Immunomedics, Inc. and Kings New York, a financial institution or individual. The Kings NY Warrant Agreement provides the opportunity for Kings New York to exercise its rights to purchase a specific number of shares of common stock from Immunomedics at a predetermined price, during a specified timeframe. This agreement helps provide a financial boost to Immunomedics by raising capital for the company through the sale of its shares. There are different types of Kings NY Warrant Agreements that may be issued by Immunomedics, Inc. Each type may have variations in terms such as the exercise price, the number of shares available for purchase, and the expiration date. Some examples of these variations include: 1. Kings NY Warrant Agreement — Series A: This type of warrant agreement may be the initial issuance of warrants by Immunomedics, Inc., granting Kings New York the right to purchase a specific number of shares of common stock at a predetermined price. 2. Kings NY Warrant Agreement — Series B: If Immunomedics decides to issue additional warrants at a later date, it could be referred to as the Series B Kings NY Warrant Agreement. This agreement would again specify the terms and conditions for the purchase of shares by Kings New York. 3. Kings NY Warrant Agreement — Exercised Warrants: This refers to the warrants from the Kings NY Warrant Agreement that have been exercised, meaning Kings New York has utilized its right to purchase the specified number of shares at the agreed-upon price. 4. Kings NY Warrant Agreement — Expired Warrants: These are warrants that have reached their expiration date without being exercised. Once expired, these warrants are no longer valid, and Kings New York loses its right to purchase shares at the predetermined price. The Kings New York Warrant Agreement of Immunomedics, Inc. is an important financial instrument that provides an opportunity for Kings New York to invest in Immunomedics' common stock at a predetermined price, benefiting both parties involved.